−12.02 MEUR
485.00 KEUR
29.02 K
About EPIGENOMICS AG (KONV. AKTIEN)
Sector
Industry
Headquarters
Berlin
Website
Employees (FY)
34
Founded
2000
ISIN
DE000A37FT41
FIGI
BBG000F1MBK9
Epigenomics AG is a molecular diagnostics company, which engages in the development and commercializing of proprietary products for the screening and diagnosis of cancer. It offers Epi proColon, a blood-based test for the early detection of colorectal cancer; Epi proLung, a confirmatory test that aids in the diagnosis of lung cancer, Epi BiSKit, a kit for the preparation of purified, bisulfite-converted DNA and, HCCBloodTest, a blood test for cirrhotic patients at high-risk for the development of hepatocellular carcinoma. The comapny was founded by Oliver Schacht, Christian Piepenbrock, Kurt Berlin, Jörn Walter, and Ivo Gut on April 30, 1997 and is headquartered in Berlin, Germany.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of ECX is 1.54 EUR — it has increased by 3.03% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SWB exchange EPIGENOMICS AG (KONV. AKTIEN) stocks are traded under the ticker ECX.
EPIGENOMICS AG (KONV. AKTIEN) is going to release the next earnings report on May 8, 2024. Keep track of upcoming events with our Earnings Calendar.
Yes, you can track EPIGENOMICS AG (KONV. AKTIEN) financials in yearly and quarterly reports right on TradingView.
Like other stocks, ECX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EPIGENOMICS AG (KONV. AKTIEN) stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 34.00 employees. See our rating of the largest employees — is EPIGENOMICS AG (KONV. AKTIEN) on this list?